FDA.reportPublic FDA data

triamcinolone acetonide 1 MG/ML Topical Cream [Triderm]

RxCUI
1085773
RxNorm name
triamcinolone acetonide 1 MG/ML Topical Cream [Triderm]
Display name
TRIDERM (Topical)
Full name
triamcinolone acetonide 1 MG/ML Topical Cream [Triderm]
Term type
SBD
Status
Active
Strength
0.1%
Dose form
Cream
Route
Topical
Updated
2026-06-14 07:05:19

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022011
Active start
022011
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
triamcinolone acetonide1 MG / 1 MLtriamcinolonetriamcinolone acetonide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Cream316982

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
triamcinolone10759

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRTriderm 0.1 % Topical Cream1NAMES
RxNorm Nametriamcinolone acetonide 1 MG/ML Topical Cream [Triderm]1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID2c7fee2c-6f57-4de4-8803-98c0b31b07c31CODES
RxCUI10857731CODES
MMSL_CODEBD33521CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0316-0170-010316-0170TRIDERM Triamcinolone AcetonideCrown LaboratoriesANDA088042
0316-0170-020316-0170TRIDERM Triamcinolone AcetonideCrown LaboratoriesANDA088042
0316-0170-030316-0170TRIDERM Triamcinolone AcetonideCrown LaboratoriesANDA088042

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA0880420316-0170TRIDERM Triamcinolone AcetonideANDACrown Laboratories

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 4 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00316017001rxnav_ndcsyes
00316017002rxnav_ndcsyes
00316017003rxnav_ndcsyes
00316017030rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TRIDERMTRIAMCINOLONE ACETONIDECrown Laboratories2c7fee2c-6f57-4de4-8803-98c0b31b07c32026-01-12Adverse reactionsExact identifier
ndc (package): 0316-0170-02
ndc (package): 0316-0170-01
ndc (package): 0316-0170-03
ndc (product): 0316-0170
ndc11 (package): 00316017003
ndc11 (package): 00316017002
ndc11 (package): 00316017001
rxcui: 1085773

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2c7fee2c-6f57-4de4-8803-98c0b31b07c3Triderm 0.1 % Topical Cream [PSN] · triamcinolone acetonide 1 MG/ML Topical Cream [Triderm] [SBD] · Triderm 0.1 % Topical Cream [SY] · Triderm 1 MG/ML Topical Cream [SY]426TRIDERM (Triamcinolone Acetonide Cream USP), 0.025%, 0.1%, 0.5%20260112

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
2c7fee2c-6f57-4de4-8803-98c0b31b07c3TRIDERM (Triamcinolone Acetonide Cream USP), 0.025%, 0.1%, 0.5%Crown Laboratories20260112
2c7fee2c-6f57-4de4-8803-98c0b31b07c3TRIDERM (Triamcinolone Acetonide Cream USP), 0.025%, 0.1%, 0.5%Crown Laboratories20251104
2c7fee2c-6f57-4de4-8803-98c0b31b07c3TRIDERM (Triamcinolone Acetonide Cream USP), 0.025%, 0.1%, 0.5%Crown Laboratories20231024
1f383a8b-e39b-4ab8-ac32-84311fc89accNational Council for Prescription Drug Programs20120724
2e97eb3f-bd70-4dd7-b1d6-b5d280cc607dNational Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC05AACorticosteroidsATC1-4triamcinolone
ATCR01ADCorticosteroidsATC1-4triamcinolone
ATCA01ACCorticosteroids for local oral treatmentATC1-4triamcinolone
ATCD07ABCorticosteroids, moderately potent (group II)ATC1-4triamcinolone
ATCD07XBCorticosteroids, moderately potent, other combinationsATC1-4triamcinolone
ATCS01BACorticosteroids, plainATC1-4triamcinolone
ATCR03BAGlucocorticoidsATC1-4triamcinolone
ATCH02ABGlucocorticoidsATC1-4triamcinolone
FDASPLN0000175576CorticosteroidEPChas_epctriamcinolone
FDASPLN0000175576CorticosteroidEPChas_epctriamcinolone acetonide
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moatriamcinolone acetonide
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moatriamcinolone
MEDRTD014221TriamcinoloneCHEMhas_ingredienttriamcinolone
MEDRTD014222Triamcinolone AcetonideCHEMhas_ingredienttriamcinolone acetonide
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treattriamcinolone acetonide
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treattriamcinolone
MEDRTD000743Anemia, HemolyticDISEASEmay_treattriamcinolone acetonide
MEDRTD000743Anemia, HemolyticDISEASEmay_treattriamcinolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventtriamcinolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventtriamcinolone acetonide
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventtriamcinolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventtriamcinolone acetonide
MEDRTD001249AsthmaDISEASEmay_preventtriamcinolone
MEDRTD001249AsthmaDISEASEmay_preventtriamcinolone acetonide
MEDRTD001607BerylliosisDISEASEmay_treattriamcinolone acetonide
MEDRTD001607BerylliosisDISEASEmay_treattriamcinolone
MEDRTD001986Bronchial SpasmDISEASEmay_treattriamcinolone
MEDRTD001986Bronchial SpasmDISEASEmay_treattriamcinolone acetonide
MEDRTD003093Colitis, UlcerativeDISEASEmay_treattriamcinolone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treattriamcinolone acetonide
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treattriamcinolone
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treattriamcinolone acetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriamcinolone acetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriamcinolone
MEDRTD004342Drug HypersensitivityDISEASEci_withtriamcinolone acetonide
MEDRTD004342Drug HypersensitivityDISEASEci_withtriamcinolone
MEDRTD004892Erythema MultiformeDISEASEmay_treattriamcinolone
MEDRTD004892Erythema MultiformeDISEASEmay_treattriamcinolone acetonide
MEDRTD005148Facial DermatosesDISEASEmay_treattriamcinolone
MEDRTD005148Facial DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD005533Foot DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD005533Foot DermatosesDISEASEmay_treattriamcinolone
MEDRTD006229Hand DermatosesDISEASEmay_treattriamcinolone
MEDRTD006229Hand DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD006934HypercalcemiaDISEASEmay_treattriamcinolone acetonide
MEDRTD006934HypercalcemiaDISEASEmay_treattriamcinolone
MEDRTD007239InfectionsDISEASEci_withtriamcinolone acetonide
MEDRTD007239InfectionsDISEASEci_withtriamcinolone
MEDRTD007249InflammationDISEASEmay_treattriamcinolone acetonide
MEDRTD007249InflammationDISEASEmay_treattriamcinolone
MEDRTD007868Leg DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD007868Leg DermatosesDISEASEmay_treattriamcinolone
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treattriamcinolone acetonide
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treattriamcinolone
MEDRTD009103Multiple SclerosisDISEASEmay_treattriamcinolone
MEDRTD009103Multiple SclerosisDISEASEmay_treattriamcinolone acetonide
MEDRTD009181MycosesDISEASEci_withtriamcinolone
MEDRTD009181MycosesDISEASEci_withtriamcinolone acetonide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treattriamcinolone acetonide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treattriamcinolone
MEDRTD010392PemphigusDISEASEmay_treattriamcinolone
MEDRTD010392PemphigusDISEASEmay_treattriamcinolone acetonide
MEDRTD012216Rheumatic DiseasesDISEASEmay_treattriamcinolone acetonide
MEDRTD012216Rheumatic DiseasesDISEASEmay_treattriamcinolone
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattriamcinolone
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattriamcinolone acetonide
MEDRTD012536Scalp DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD012536Scalp DermatosesDISEASEmay_treattriamcinolone
MEDRTD012713Serum SicknessDISEASEmay_treattriamcinolone
MEDRTD012713Serum SicknessDISEASEmay_treattriamcinolone acetonide
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treattriamcinolone acetonide
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treattriamcinolone
MEDRTD013224Status AsthmaticusDISEASEci_withtriamcinolone
MEDRTD013224Status AsthmaticusDISEASEci_withtriamcinolone acetonide
MEDRTD013585SynovitisDISEASEmay_treattriamcinolone acetonide
MEDRTD013585SynovitisDISEASEmay_treattriamcinolone
MEDRTD013966ThyroiditisDISEASEmay_treattriamcinolone
MEDRTD013966ThyroiditisDISEASEmay_treattriamcinolone acetonide
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treattriamcinolone acetonide
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treattriamcinolone
MEDRTD014605UveitisDISEASEmay_treattriamcinolone
MEDRTD014605UveitisDISEASEmay_treattriamcinolone acetonide
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moatriamcinolone acetonide
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moatriamcinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moatriamcinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moatriamcinolone acetonide
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_petriamcinolone acetonide
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_petriamcinolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_petriamcinolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_petriamcinolone acetonide
MEDRTN0000008571Decreased Cytokine ActivityPEhas_petriamcinolone acetonide
MEDRTN0000008571Decreased Cytokine ActivityPEhas_petriamcinolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_petriamcinolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_petriamcinolone acetonide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_petriamcinolone acetonide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_petriamcinolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_petriamcinolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_petriamcinolone acetonide
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_petriamcinolone acetonide
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_petriamcinolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_petriamcinolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_petriamcinolone acetonide
MEDRTN0000008841Decreased Protein SynthesisPEhas_petriamcinolone acetonide
MEDRTN0000008841Decreased Protein SynthesisPEhas_petriamcinolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_petriamcinolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_petriamcinolone acetonide
MEDRTN0000009739Lipid Metabolism AlterationPEhas_petriamcinolone acetonide
MEDRTN0000009739Lipid Metabolism AlterationPEhas_petriamcinolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_petriamcinolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_petriamcinolone acetonide

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH1 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA088042
NAMESPrescribable SynonymTriderm 0.1 % Topical Cream
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon